3,4-Diaminopyridine
Specifications
54-96-6CAS Number
200-220-9EC Number
pyridine-3,4-diamineIUPAC Name
C5H7N3Chemical Formula
109.13 g/molMolecular Weight
3,4-DIAMINOPYRIDINE; pyridine-3,4-diamine; 54-96-6; Amifampridine; 3,4-Pyridinediamine; 3,4-DAP; 4,5-Diaminopyridine; Pyridine, 3,4-diamino-; SC10; 3,4 Diaminopyridine; amifampridina; DTXSID6046715; RU4S6E2G0J; NSC-521760; DTXCID4026715; 5-22-11-00266 (Beilstein Handbook Reference); NSC521760; amifampridinum; RefChem:54154; N07XX05; 200-220-9; Diamino-3,4 pyridine; amifampridin; Dynamine; Ruzurgi; MFCD00006401; 3-amino-4-pyridinylamine; CHEMBL354077; NCGC00167560-01; CAS-54-96-6; SMR000752913; Amifampridine [INN]; EINECS 200-220-9; UNII-RU4S6E2G0J; NSC 521760; BRN 0110232; 54-96-6 (free base); Amifampridine [USAN:INN:BAN]; Ruzurgi (TN); Pyridine,4-diamino-; 3,4-diamino pyridine; 3,4-diamino-pyridine; 3,4-Diammoniopyridinium; pyridine, 4,5-diamino-; AMIFAMPRIDINE [MI]; WLN: T6NJ CZ DZ; Amifampridine (USAN/INN); 4-DAP; AMIFAMPRIDINE [USAN]; SCHEMBL21273; MLS001304911; MLS001333181; MLS001333182; AMIFAMPRIDINE [MART.]; AMIFAMPRIDINE [WHO-DD]; GTPL8032; orb1222060; orb1302811; SCHEMBL1431953; SCHEMBL7789064; AMIFAMPRIDINE [EMA EPAR]; SCHEMBL28800254; SCHEMBL29354458; 3,4-Diamino[3,4-?]pyridine; CHEBI:135948; HMS2233K06; HMS5083P21; AMIFAMPRIDINE [ORANGE BOOK]; ALBB-005969; Tox21_112555; 3,4 DIAMINOPYRIDINE [VANDF]; BBL013269; BDBM50416493; CL0116; EBC-03947; NSC790505; s4622; SBB004341; STK503647; AKOS000672436; Tox21_112555_1; CCG-304141; DB11640; FD07065; NSC-790505; PB48915; PS-9273; NCGC00167560-02; BP-12781; HY-14946; DB-011105; D1149; NS00021207; ST50946583; T4497; EN300-69695; D10228; AC-907/34116043; F043674; Q411707; BRD-K80262108-001-07-0; F0001-1409; Z385438794; InChI=1/C5H7N3/c6-4-1-2-8-3-5(4)7/h1-3H,7H2,(H2,6,8; L89Synonyms
